Home > Healthcare > Analytical Instruments > Molecular Analysis > PCR Technologies Market

PCR Technologies Market Share

Report ID: GMI5551
Published Date: May 2024
Report Format: PDF

Download Free Sample

PCR Technologies Market Share

The PCR technologies sector is competitive in nature, with a mix of major global and smaller to medium-sized companies competing for market share. A pivotal aspect of market strategy involves the continual introduction of innovative products leveraging diverse technologies. Notably, prominent industry players command considerable influence in this dynamic landscape, often driving forward advancements through substantial investments in research and development. Additionally, strategic alliances, acquisitions, and mergers are instrumental in fortifying market positions and expanding global footprint amidst evolving regulatory landscapes.

PCR Technologies Market Companies

Some of the eminent market participants operating in the PCR technologies industry include:

Abbott Laboratories
Agilent Technologies, Inc.
bioMérieux S.A.
Bio-Rad Laboratories, Inc.
Danaher Corporation
Eppendorf SE
F. Hoffmann-LA Roche Ltd.
Illumina, Inc.
Merck KGaA
New England Biolabs
Promega Corporation
QIAGEN N.V.
Standard Biotools Inc.
Takara Holdings Inc.
Thermo Fisher Scientific Inc.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

PCR technologies market size was USD 14.4 billion in 2023 and is expected to register 8.1% CAGR from 2024-2032 owing to the escalating prevalence of infectious diseases and genetic disorders worldwide.

PCR technologies industry from the kits & reagents segment and is expected to reach USD 11.6 billion by 2032 due to the rising demand for accurate molecular diagnostic tests, particularly in infectious diseases and oncology.

The U.S. PCR technologies industry is expected to record USD 10.4 billion by 2032 due to increased investment in biomedical research, significantly supported by government funding initiatives and grants in the region.

Danaher Corporation, Eppendorf SE, F. Hoffmann-LA Roche Ltd., Illumina, Inc., Merck KGaA, New England Biolabs, Promega Corporation, QIAGEN N.V., Standard Biotools Inc., Takara Holdings Inc., and Thermo Fisher Scientific Inc., are some of the major PCR technologies companies worldwide.